Evidence map›Paper›PMID 41617468›Full record

ArticleRNA (New York, N.Y.)2026

RK-33 inhibits the OC43 coronavirus and induces stress granules via DDX3X-independent mechanisms.

Cody J S Hecht, Roy R Parker

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cody J S HechtDepartment of Biochemistry, University of Colorado Boulder, Boulder, Colorado 80303, USA.ORCID 0000-0003-2201-035X
Roy R ParkerDepartment of Biochemistry, University of Colorado Boulder, Boulder, Colorado 80303, USA roy.parker@colorado.edu.ORCID 0000-0002-8412-4152

Funding

Predoctoral Training Program in Signaling and Cellular Regulation INCLUDE Down Syndrome SupplementT32GM142607 · NIGMS · UNIVERSITY OF COLORADO · PI Sabrina Leigh Spencer, Tin Tin Su · 2021 to 2026
$3.6M
NIGMS NIH HHS T32 GM142607
6 · The paper itself

Abstract

DDX3X is a human DEAD-box RNA helicase with multiple functions in RNA metabolism. Previous studies have suggested that DDX3X is an important proviral host factor for numerous RNA viruses, including HIV, HCV, and SARS-CoV-2, and may be targetable with inhibitors such as RK-33 for therapeutic benefit. In exploring the role of DDX3X and its homolog DDX3Y in coronavirus replication, we found that the DDX3X inhibitor RK-33 inhibits propagation of the OC43 coronavirus through a DDX3X/DDX3Y-independent mechanism. Knockdowns of DDX3X or DDX3X and DDX3Y had little effect on OC43 growth in multiple cell lines, yet RK-33 treatment reduced OC43 replication in the presence or absence of DDX3 proteins. We observed that RK-33 stimulates the integrated stress response independently of DDX3 proteins to cause stress granule formation, although this is not the primary mechanism by which RK-33 suppresses OC43. Together, our results show that DDX3 proteins are likely not general pro-coronaviral host factors, and caution should be used in interpreting results with RK-33 given its off-target activity.

Indexed as

Antiviral AgentsDEAD-box RNA HelicasesImidazolesStress GranulesAzepinesCell LineHumansSARS-CoV-2Virus Replication3,7-dihydro-3,7-bis((4-methoxyphenyl)methyl)-2H-diimidazo(4,5-d:4',5'-f)(1,3)diazepin-2-oneAntiviral AgentsAzepinesDDX3X protein, humanDEAD-box RNA HelicasesImidazolesDDX3Xintegrated stress responseOC43RK-33stress granules

Identifiers

PMID41617468
PMCPMC13085917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.